Form 4: Bio-Rad Laboratories EVP Sedat Evran Reports Stock Transactions
SEC Form 4 Filing
Sedat Evran, EVP of Global Supply Chain at Bio-Rad Laboratories, reports the vesting of restricted stock units and related tax withholding.
Summary
- On October 20, 2024, Sedat Evran, EVP of Global Supply Chain at Bio-Rad Laboratories, acquired 1,044 shares of Bio-Rad A Common Stock upon the vesting of restricted stock units.
- Simultaneously, 335 shares were disposed of to cover tax obligations related to the vesting.
- Following these transactions, Evran directly owns 853.14 shares of Bio-Rad A Common Stock.
- Evran also holds 3,132 restricted stock units, each representing a contingent right to receive one share of Bio-Rad Class A common stock.
- These restricted stock units were granted on October 20, 2023, and vest in four equal annual installments.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential insider trading activity.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related sales.
Key Dates
| Date | Description |
|---|---|
| 10/20/2023 | Reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12/31/2023 | Acquisition of 49.0480 shares under the Bio-Rad Employee Stock Purchase Plan. |
| 03/31/2024 | Acquisition of 41.3870 shares under the Bio-Rad Employee Stock Purchase Plan. |
| 06/30/2024 | Acquisition of 33.7050 shares under the Bio-Rad Employee Stock Purchase Plan. |
| 10/20/2024 | Vesting of restricted stock units and related stock transactions. |
| 10/22/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.